Literature DB >> 19179909

Rupture of a cerebral arteriovenous malformation in a patient treated with bevacizumab.

Tawee Tanvetyanon, Ryan Murtagh, Gerold Bepler.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19179909     DOI: 10.1097/JTO.0b013e318195a642

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN: 1556-0864            Impact factor:   15.609


× No keyword cloud information.
  8 in total

Review 1.  Neurological Complications of Therapeutic Monoclonal Antibodies: Trends from Oncology to Rheumatology.

Authors:  Chandler Gill; Stasia Rouse; Ryan D Jacobson
Journal:  Curr Neurol Neurosci Rep       Date:  2017-08-17       Impact factor: 5.081

2.  Intracranial hemorrhage in patients treated with bevacizumab: report of two cases.

Authors:  Takeshi Nishimura; Makoto Furihata; Hideyuki Kubo; Masao Tani; Senichiro Agawa; Ryuhei Setoyama; Tomikatsu Toyoda
Journal:  World J Gastroenterol       Date:  2011-10-21       Impact factor: 5.742

3.  Cerebrovascular events after bevacizumab treatment: an early and severe complication.

Authors:  Raymond C S Seet; Alejandro A Rabinstein; Paul E Lindell; Joon H Uhm; Eelco F Wijdicks
Journal:  Neurocrit Care       Date:  2011-12       Impact factor: 3.210

Review 4.  Brain arteriovenous malformation modeling, pathogenesis, and novel therapeutic targets.

Authors:  Wanqiu Chen; Eun-Jung Choi; Cameron M McDougall; Hua Su
Journal:  Transl Stroke Res       Date:  2014-04-12       Impact factor: 6.829

Review 5.  Causality assessment between reported fatal cerebral haemorrhage and suspected drugs: developing a new algorithm based on the analysis of the Japanese Adverse Event Report (JADER) database and literature review.

Authors:  Miki Ohta
Journal:  Eur J Clin Pharmacol       Date:  2021-04-07       Impact factor: 2.953

6.  Inhibition of pathological brain angiogenesis through systemic delivery of AAV vector expressing soluble FLT1.

Authors:  F Shen; L Mao; W Zhu; M T Lawton; P Pechan; P Colosi; Z Wu; A Scaria; H Su
Journal:  Gene Ther       Date:  2015-06-19       Impact factor: 5.250

7.  Proof-of-concept single-arm trial of bevacizumab therapy for brain arteriovenous malformation.

Authors:  Rachel Muster; Nerissa Ko; Wade Smith; Hua Su; Melissa A Dickey; Jeffrey Nelson; Charles E McCulloch; Patricia K Sneed; Jennifer L Clarke; David A Saloner; Laura Eisenmenger; Helen Kim; Daniel L Cooke
Journal:  BMJ Neurol Open       Date:  2021-03-17

Review 8.  Review of treatment and therapeutic targets in brain arteriovenous malformation.

Authors:  Peipei Pan; Shantel Weinsheimer; Daniel Cooke; Ethan Winkler; Adib Abla; Helen Kim; Hua Su
Journal:  J Cereb Blood Flow Metab       Date:  2021-06-23       Impact factor: 6.960

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.